CLINICAL THERAPEUTIC AND ADJUVANT CONDUCT IN ALCOHOLIC HEPATITIS
CLINICAL THERAPEUTIC AND ADJUVANT CONDUCT IN ALCOHOLIC HEPATITIS
Keywords:
Alcoholic Liver Desease, Alcoholic Hepatitis, TreatmentAbstract
Alcoholic liver disease one of the worst problems arising from alcohol abuse. It is manifested by liver sequelae, as: steatosis, hepatitis, fibrosis and cirrhosis. The objective of the study is identify which medications and conducts have proven benefits in the treatment of AH. An integrative review was carried out, based on the guiding question: which medications and conduct shave proven benefits in the treatment of alcoholic hepatitis? The search for the articles place in LILACS, SCIELO and MEDLINE using descriptors registered in the DeCS: Alcoholic Liver Disease, Treatment and Alcoholic Hepatitis. The inclusion criteria: full texts, human studies, guidelines, cohort studies, clinical trials, systematic, integrative reviews and meta-analysis, in the last 10 years. Studies shown that alcohol cessation is the first and most important measure in the management of alcoholic hepatitis. Corticosteroids remain a primary drug option to treat alcoholic hepatitis. Pentoxifylline, although used in cases that culminate in hepatorenal syndrome, has questionable benefits. Early liver transplantation is indicated when there is no response to corticosteroids. There are adjuvant medications such as antidepressants and anticonvulsants in the context of treatment against alcohol abuse. The management of alcoholic hepatitis in the emergency department requires a multidisciplinary approach with an emphasis on dietary, medication and behavioral issues, using specific medications such as corticosteroids and adjuvants to alcoholism, in addition to adequate nutritional and behavioral therapy to reduce morbidity and mortality. liver transplantation, although it is still the definitive therapy, does not yet have a specific protocol for its indication.
Downloads
References
Chayanupatkul, M., & Liangpunsakul, S. (2016). Alcoholic hepatitis: a comprehensive review of pathogenesis and treatment. World Journal of Gastroenterology: WJG, 20(20), 6279.
Choudhary, N. S., Saigal, S., Gautam, D., Saraf, N., Rastogi, A., Goja, S., & Rastogi, V. (2019). Good outcome of living donor liver transplantation for severe alcoholic hepatitis not responding to medical management: A single center experience of 39 patients. Alcohol, 77, 27-30.
Crabb, D. W., Bataller, R., Chalasani, N. P., Kamath, P. S., Lucey, M., Mathurin, P., & Nagy, L. (2016). Standard definitions and common data elements for clinical trials in patients with alcoholic hepatitis: recommendation from the NIAAA Alcoholic Hepatitis Consortia. Gastroenterology, 150(4), 785-790.
Fialla, A. D., Israelsen, M., Hamberg, O., Krag, A., & Gluud, L. L. (2016). Nutritional therapy in cirrhosis or alcoholic hepatitis: a systematic review and meta‐analysis. Liver International, 35(9), 2072-2078.
Guirguis, J., Chhatwal, J., Dasarathy, J., Rivas, J., McMichael, D., Nagy, L. E., & Dasarathy, S. (2016). Clinical impact of alcohol‐related cirrhosis in the next decade: estimates based on current epidemiological trends in the United States. Alcoholism: Clinical and Experimental Research, 39(11), 2085-2094.
Gustot, T., Fernandez, J., Szabo, G., Albillos, A., Louvet, A., Jalan, R., & Moreno, C. (2017). Sepsis in alcohol-related liver disease. Journal of hepatology, 67(5), 1031-1050.
Jaruvongvanich, V., Sanguankeo, A., & Upala, S. (2016). Effect of SIRS and sepsis on mortality in alcoholic hepatitis: A systematic review and meta-analysis. Turk J Gastroenterol, 27(5), 458-463.
Louvet, A., Labreuche, J., Artru, F., Boursier, J., Kim, D. J., O’Grady, J., & Diaz, E. (2016). Combining data from liver disease scoring systems better predicts outcomes of patients with alcoholic hepatitis. Gastroenterology, 149(2), 398-406.
Melo, A. P. S., França, E. B., Malta, D. C., Garcia, L. P., Mooney, M., & Naghavi, M. (2017). Mortalidade por cirrose, câncer hepático e transtornos devidos ao uso de álcool: Carga Global de Doenças no Brasil, 1990 e 2015. Revista Brasileira de Epidemiologia, 20, 61-74.
Njei, B. A. D., McCarty, T. R., & Fortune, B. E. (2016). Corticosteroids versus pentoxifylline for severe alcoholic hepatitis: a sequential analysis of randomized controlled trials. Journal of clinical gastroenterology, 50(10), 871.
Osna, N. A., Donohue Jr, T. M., & Kharbanda, K. K. (2017). Alcoholic liver disease: Pathogenesis and current management. Alcohol research: current reviews, 38(2), 147.
Poole, R., Kennedy, O. J., Roderick, P., Fallowfield, J. A., Hayes, P. C., & Parkes, J. (2017). Coffee consumption and health: umbrella review of meta-analyses of multiple health outcomes. bmj, 359.
Roerecke, M., & Rehm, J. (2016). Cause-specific mortality risk in alcohol use disorder treatment patients: a systematic review and meta-analysis. International journal of epidemiology, 43(3), 906-919.
Seitz, H. K., Bataller, R., Cortez-Pinto, H., Gao, B., Gual, A., Lackner, C., & Tsukamoto, H. (2018). Alcoholic liver disease. Nature Reviews Disease Primers, 4(1), 1-22.
Singal, A. K., Bataller, R., Ahn, J., Kamath, P. S., & Shah, V. H. (2018). ACG clinical guideline: alcoholic liver disease. The American journal of gastroenterology, 113(2), 175.
Singal, A. K., Kodali, S., Vucovich, L. A., Darley‐Usmar, V., & Schiano, T. D. (2016). Diagnosis and treatment of alcoholic hepatitis: a systematic review. Alcoholism: Clinical and Experimental Research, 40(7), 1390-1402.
Singal, A. K., Louvet, A., Shah, V. H., & Kamath, P. S. (2018). Grand rounds: alcoholic hepatitis. Journal of hepatology, 69(2), 534-543.
Singh, S., Khera, R., Allen, A. M., Murad, M. H., & Loomba, R. (2016). Comparative effectiveness of pharmacological interventions for nonalcoholic steatohepatitis: a systematic review and network meta‐analysis. Hepatology, 62(5), 1417-1432.
Sousa, M. N. A., & Santos, E. V. L. (2016). Medicina e pesquisa: um elo possível. Curitiba: Editora Prismas.
Streba, L. A. M., Vere, C. C., Streba, C. T., & Ciurea, M. E. (2014). Focus on alcoholic liver disease: From nosography to treatment. World Journal of Gastroenterology: WJG, 20(25), 8040.
Tilg, H., Cani, P. D., & Mayer, E. A. (2016). Gut microbiome and liver diseases. Gut, 65(12), 2035-2044.
Vuittonet, C. L., Halse, M., Leggio, L., Fricchione, S. B., Brickley, M., Haass-Koffler, C. L., & Kenna, G. A. (2014). Pharmacotherapy for alcoholic patients with alcoholic liver disease. American journal of health-system pharmacy, 71(15), 1265-1276.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2020 Brazilian Journal of Production Engineering - BJPE

This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
